At ATS 2025, data from the Phase III MATINEE trial reinforced the efficacy of Nu...
At a recent gathering, experts in the Swiss biotech and pharma sector underscore...
The sale brings attention back to privacy concerns as Regeneron now controls gen...
The Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) ...
Experts predict growing pains as the life sciences sector moves to adapt to the ...
US President Donald Trump has resurrected a drug pricing plan that equates to In...
The US Food and Drug Administration has granted approval to Amneal Pharmaceutica...
The executive order instructs the FDA to expedite the approval process for domes...
A record number of biosimilars were approved by the FDA in 2024, with 2025 set t...
AGC Biologics has collaborated with Quell Therapeutics to advance the developmen...
The deal gives Lilly access to the company’s RNA-editing platform to develop the...
The 2025 Pharmaceutical Technology Excellence Awards are now open for submission...
Sanofi joins fellow big pharma companies in bolstering US presence amid Trump’s ...
From predictive analytics to robotic warehousing, automation is unlocking new ef...
